Position in MRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$33,725,210
+$2,163,039 QoQ
Shares Held
262,453
+0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
3.12%
of 13F equity value
Holder Rank
#405
of 3,778 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $69,576,548 across 11 Drug Manufacturers - General names. MRK ranks #1 (48.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
262,453 | $33,725,210 | |
| 2 | JNJ |
Johnson & Johnson
|
43,125 | $10,952,456 | |
| 3 | LLY |
ELI LILLY & Co
|
6,902 | $8,278,466 | |
| 4 | ABBV |
AbbVie Inc.
|
29,656 | $7,462,635 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
55,185 | $3,179,759 | |
| 6 | AMGN |
Amgen Inc
|
4,077 | $1,476,363 | |
| 7 | NVS |
Novartis AG
|
8,348 | $1,308,298 | |
| 8 | AZN |
Astrazeneca PLC
|
6,659 | $1,262,679 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,725,210 | 262,453 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $31,562,171 | 262,384 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $27,511,911 | 261,371 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $22,533,526 | 268,480 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $21,244,248 | 268,371 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $24,650,968 | 274,632 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $28,323,448 | 284,715 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $33,393,340 | 294,059 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $36,960,613 | 298,551 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $38,852,545 | 294,449 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $31,735,067 | 291,094 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $29,919,226 | 290,619 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $33,700,572 | 292,058 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $30,836,715 | 289,846 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $32,632,503 | 294,119 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $25,579,190 | 297,018 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $27,005,101 | 296,206 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $24,287,210 | 296,005 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $23,562,431 | 307,443 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $22,935,289 | 305,356 | Shares | Sole | 2021-11-04 | |
| 2021-03-31 | $23,936,843 | 310,505 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $25,335,820 | 309,729 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $24,363,006 | 293,707 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $21,790,211 | 281,782 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $21,999,060 | 285,925 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||